Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report)’s share price gapped down before the market opened on Thursday. The stock had previously closed at $10.00, but opened at $8.55. Haleon shares last traded at $8.5550, with a volume of 8,658,524 shares traded.
Analyst Ratings Changes
Several brokerages recently commented on HLN. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a research report on Wednesday, September 23rd. Morgan Stanley restated an “overweight” rating on shares of Haleon in a report on Thursday, August 6th. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Haleon in a report on Tuesday, August 11th. Zacks Research cut Haleon from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Haleon in a report on Wednesday, September 9th. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $4.90.
Check Out Our Latest Stock Analysis on Haleon
Haleon Stock Down 15.9%
The company has a current ratio of 0.69, a quick ratio of 0.52 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $37.03 billion, a PE ratio of 21.53, a P/E/G ratio of 2.32 and a beta of 0.14. The stock’s fifty day simple moving average is $9.59 and its 200-day simple moving average is $9.79.
Hedge Funds Weigh In On Haleon
Institutional investors have recently modified their holdings of the business. Profund Advisors LLC lifted its stake in Haleon by 12.1% in the third quarter. Profund Advisors LLC now owns 55,100 shares of the company’s stock valued at $496,000 after purchasing an additional 5,929 shares during the last quarter. Vise Technologies Inc. grew its holdings in Haleon by 48.0% during the third quarter. Vise Technologies Inc. now owns 79,286 shares of the company’s stock valued at $714,000 after purchasing an additional 25,697 shares during the period. Founders Financial Securities LLC increased its position in Haleon by 2.3% in the third quarter. Founders Financial Securities LLC now owns 281,649 shares of the company’s stock worth $2,535,000 after buying an additional 6,205 shares during the last quarter. D.A. Davidson & CO. increased its position in Haleon by 22.0% in the third quarter. D.A. Davidson & CO. now owns 18,462 shares of the company’s stock worth $166,000 after buying an additional 3,330 shares during the last quarter. Finally, VestGen Advisors LLC raised its stake in shares of Haleon by 17.8% in the third quarter. VestGen Advisors LLC now owns 16,848 shares of the company’s stock valued at $152,000 after buying an additional 2,550 shares during the period. 6.67% of the stock is owned by institutional investors.
About Haleon
Haleon plc (NYSE: HLN) is a global consumer health company that develops, manufactures and markets over-the-counter medicines, oral health products, vitamins and supplements. Its portfolio is organized around categories including pain relief, respiratory health, digestive health, therapeutic oral care, everyday oral care, vitamins and minerals, and skin health.
Haleon’s well-known brands include Sensodyne, Polident, parodontax, Centrum, Advil, Voltaren, Panadol, Otrivin and Theraflu. The company’s products are sold through pharmacies, supermarkets, retailers and e-commerce channels, serving consumers in markets around the world.
Haleon was established as an independent consumer health business following its demerger from GSK in July 2022.
Featured Stories
- Five stocks we like better than Haleon
- Plugging In: Vertiv Cashes In On AI Demand
- Visa’s Toll Booth Keeps Collecting, But the Price Is Rising
- Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps Growing
- Why Meta Platform’s $100 Billion Financing Plan Is A Boon for Chip Giant Broadcom
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
